Almujtama Alraida Medical Co. announces the appointment of the Chairman and the Vice Chairman of the Board of Directors, the formation of the Board Committees, and the appointment of the Secretary of the Board of Directors.

Element List	Explanation
Announcement Detail	With reference to the announcement by Almujtama Alraida Medical Co. published on the Saudi Exchange (Tadawul) website on July 27, 2026, regarding the results of the Ordinary General Assembly meeting held on July 26, 2026 which included the election of Board members for the new term commencing on August 1, 2026, for a four-year period ending on July 31, 2030 The Company wishes to announce the Board of Directors' resolutions issued on August 1, 2026, which include the following: First: Approval of the appointment of the Chairman and Vice Chairman of the Board of Directors as follows: - Appointment of Mr. Omar Yousef Khojah as Chairman of the Board of Directors. - Appointment of Mr. Fahad Abdullah Al-Samih as Vice Chairman of the Board of Directors. Second: Approval of the formation of the Audit Committee comprising the following members: 1- Mr. Maher Abdullah Al-Madani – Chairman (from outside the Board). 2- Mr. Karim Bachite – Member (Independent). 3- Mr. Ahmed Ibrahim Qasim – Member (from outside the Board). Third: Approval of the formation of the Nomination and Remuneration Committee, comprising the following members: 1- Mr. Fahad Abdullah Al-Samih – Chairman (Independent). 2- Mr. Hamad Hamdan Al-Sourayia – Member (Independent). 3- Mr. Abdulghani Mohammed Al-Maliki – Member (from outside the Board). Fourth: Approval of the appointment of the Board of Directors’ Secretary. Fifth: Approval of the appointment of the Company’s representatives to the Capital Market Authority and the Saudi Exchange (Tadawul) for all purposes related to the Capital Market Law, the Companies Law, their implementing regulations, and other relevant laws and regulations, including the Rules on the Offer of Securities and Continuing Obligations.

Element List

Explanation

Announcement Detail

With reference to the announcement by Almujtama Alraida Medical Co. published on the Saudi Exchange (Tadawul) website on July 27, 2026, regarding the results of the Ordinary General Assembly meeting held on July 26, 2026 which included the election of Board members for the new term commencing on August 1, 2026, for a four-year period ending on July 31, 2030

The Company wishes to announce the Board of Directors' resolutions issued on August 1, 2026, which include the following:

First: Approval of the appointment of the Chairman and Vice Chairman of the Board of Directors as follows:

- Appointment of Mr. Omar Yousef Khojah as Chairman of the Board of Directors.

- Appointment of Mr. Fahad Abdullah Al-Samih as Vice Chairman of the Board of Directors.

Second: Approval of the formation of the Audit Committee comprising the following members:

1- Mr. Maher Abdullah Al-Madani – Chairman (from outside the Board).

2- Mr. Karim Bachite – Member (Independent).

3- Mr. Ahmed Ibrahim Qasim – Member (from outside the Board).

Third: Approval of the formation of the Nomination and Remuneration Committee, comprising the following members:

1- Mr. Fahad Abdullah Al-Samih – Chairman (Independent).

2- Mr. Hamad Hamdan Al-Sourayia – Member (Independent).

3- Mr. Abdulghani Mohammed Al-Maliki – Member (from outside the Board).

Fourth: Approval of the appointment of the Board of Directors’ Secretary.

Fifth: Approval of the appointment of the Company’s representatives to the Capital Market Authority and the Saudi Exchange (Tadawul) for all purposes related to the Capital Market Law, the Companies Law, their implementing regulations, and other relevant laws and regulations, including the Rules on the Offer of Securities and Continuing Obligations.